Role of the Hemagglutinin-neuraminidase Protein in the Mechanism of Paramyxovirus-cell Membrane Fusion
Overview
Affiliations
Paramyxovirus infects cells by initially attaching to a sialic acid-containing cellular receptor and subsequently fusing with the plasma membrane of the cells. Hemagglutinin-neuraminidase (HN) protein, which is responsible for virus attachment, interacts with the fusion protein in a virus type-specific manner to induce efficient membrane fusion. To elucidate the mechanism of HN-promoted membrane fusion, we characterized a series of Newcastle disease virus HN proteins whose surface residues were mutated. Fusion promotion activity was substantially altered in only the HN proteins with a mutation in the first or sixth beta sheet. These regions overlap the large hydrophobic surface of HN; thus, the hydrophobic surface may contain the fusion promotion domain. Furthermore, a comparison of the HN structure crystallized alone or in complex with 2-deoxy-2,3-dehydro-N-acetylneuraminic acid revealed substantial conformational changes in several loops within or near the hydrophobic surface. Our results suggest that the binding of HN protein to the receptor induces the conformational change of residues near the hydrophobic surface of HN protein and that this change triggers the activation of the F protein, which initiates membrane fusion.
Miller R, Durie I, Gingerich A, Elbehairy M, Branch A, Davis R Nat Commun. 2024; 15(1):10825.
PMID: 39738006 PMC: 11686389. DOI: 10.1038/s41467-024-55101-4.
Entry of Newcastle disease virus into host cells: an interplay among viral and host factors.
Deng J, Cao Y, Hu Z Arch Virol. 2024; 169(11):227.
PMID: 39428451 DOI: 10.1007/s00705-024-06157-6.
Wu X, Goebbels M, Debski-Antoniak O, Marougka K, Chao L, Smits T PLoS Pathog. 2024; 20(7):e1012371.
PMID: 39052678 PMC: 11302929. DOI: 10.1371/journal.ppat.1012371.
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
Dhanjal D, Singh R, Sharma V, Nepovimova E, Adam V, Kuca K Curr Med Chem. 2023; 31(13):1646-1690.
PMID: 37138422 DOI: 10.2174/0929867330666230503144619.
Sialidase Inhibitors with Different Mechanisms.
Keil J, Rafn G, Turan I, Aljohani M, Sahebjam-Atabaki R, Sun X J Med Chem. 2022; 65(20):13574-13593.
PMID: 36252951 PMC: 9620260. DOI: 10.1021/acs.jmedchem.2c01258.